Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04445025 · ClinicalTrials.gov registry record · Early Phase 1
Comparison Elagolix vs Depot Leuprolide Prior to Frozen Embryo Transfers in Patients With Endometriosis
A Early Phase 1 study, sponsored by Colorado Center for Reproductive Medicine.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 30
- Enrollment target
NCT04445025 is a Early Phase 1 study that has completed, run by Colorado Center for Reproductive Medicine. The registered enrollment target is 30 participants.
The verdict
NCT04445025, a Early Phase 1 study, has completed, sponsored by Colorado Center for Reproductive Medicine.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
Patients who have been previously surgically diagnosed with endometriosis and have embryos predicted to be euploid after in vitro fertilization will be divided into 2 groups via randomization. The test group will receive Elagolix for 60 days prior to starting frozen embryo transfer preparation. The control group will be given leuprolide acetate every 28 days x 2 prior to starting the frozen embryo transfer preparation. Comparative implantation rates between two groups of patients will be evaluated
Interventions
- DRUG Elagolix 200 MG
- DRUG Leuprolide Acetate 3.75 MG/ML
- DIAGNOSTIC_TEST Lab work
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2020-09-01 |
| Est. Completion | 2024-12-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04445025
The ClinicalTrials.gov registry entry for NCT04445025 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Colorado Center for Reproductive Medicine, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Elagolix 200 MG is the first listed.
NCT04445025 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04445025 about?
NCT04445025 is a clinical study titled "Comparison Elagolix vs Depot Leuprolide Prior to Frozen Embryo Transfers in Patients With Endometriosis". Patients who have been previously surgically diagnosed with endometriosis and have embryos predicted to be euploid after in vitro fertilization will be divided into 2 groups via randomization. The test group will receive Elagolix for 60 days prior to starting frozen embryo transfer preparation. The ...
What is the current status of trial NCT04445025?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2020-09-01. Estimated completion is 2024-12-30.
What interventions are being tested in trial NCT04445025?
The interventions under investigation include: Elagolix 200 MG (DRUG), Leuprolide Acetate 3.75 MG/ML (DRUG), Lab work (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04445025?
This trial is sponsored by Colorado Center for Reproductive Medicine, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.